Get the Daily Brief
Latest Biotech News
Teva Launches First Generic Weight Loss GLP-1 Amid Market Shortages
Teva Pharmaceuticals received FDA approval for the first generic glucagon-like peptide-1 (GLP-1) agonist aimed at weight management, targeting adults struggling with excess weight and adolescents...
Royalty Pharma Acquires Amgen’s Small Cell Lung Cancer Immunotherapy
Royalty Pharma secured a royalty interest in Amgen’s Imdelltra (tarlatamab-dlle), an immunotherapy for extensive-stage small cell lung cancer (ES-SCLC), in a deal worth up to $950 million....
AI Detects Covert Consciousness in Comatose Patients via Facial Movements
Researchers have developed SeeMe, an AI-powered tool that decodes subtle facial movements in comatose patients, revealing signs of covert consciousness undetectable by clinicians. By capturing...
AI Discovers Antimicrobial Compounds in Animal Venoms to Combat Resistance
Scientists wielding artificial intelligence have mined venom proteomes from snakes, spiders, and scorpions to uncover potent new antimicrobial peptides addressing the global crisis of antibiotic...
DNA-Wrapped Nanoparticles Triple CRISPR Genome Editing Efficiency
A cutting-edge technique employing DNA-wrapped nanoparticles as delivery vehicles has significantly enhanced the efficiency of CRISPR-Cas9 genome editing by threefold. This breakthrough in genetic...
Optimized Drug Regimens Improve Acute Type A Aortic Dissection Outcomes
A multicenter retrospective cohort study has yielded new evidence supporting the use of optimized pharmacological treatment protocols in managing acute type A aortic dissection, a critical...
CRISPR Deep Learning Model Pythia Boosts Genome Engineering Accuracy
Researchers have developed Pythia, a deep learning framework that predicts optimal repair templates for CRISPR-Cas9 genome editing, addressing challenges of precision, especially in non-dividing...
AI Model Revolutionizes Anticoagulation Therapy in Atrial Fibrillation
Mount Sinai researchers unveiled an advanced Graph Neural Network-based AI that analyzes large-scale electronic health records to precisely identify atrial fibrillation patients who require...
Citizen Science Powers Viral Biocontrol to Manage Australia’s Rabbit Plague
Australian researchers have leveraged citizen participation via RabbitScan to enhance the monitoring of rabbit hemorrhagic disease virus (RHDV) strains used as biocontrol agents against invasive...
Multisystem Exercises Enhance Balance and Mobility in Diabetic Neuropathy
Research demonstrates that multisystem exercise interventions significantly improve balance and functional mobility in individuals with diabetic peripheral neuropathy, a prevalent complication of...
Teva Scores FDA Nod for First Generic Weight Loss GLP-1
Teva Pharmaceuticals has secured FDA approval for the first generic glucagon-like peptide-1 (GLP-1) injectable therapy for weight loss, expanding treatment options amid high demand. The drug, a...
Royalty Pharma Acquires Amgen’s Lung Cancer Immunotherapy Rights
Royalty Pharma has acquired rights to Amgen’s Imdelltra (tarlatamab-dlle), an FDA-accelerated approval immunotherapy for extensive-stage small cell lung cancer (ES-SCLC), in a deal valued up to...
AI Model Refines Stroke Prevention in Atrial Fibrillation
Researchers at Mount Sinai have developed a Graph Neural Network (GNN)-based artificial intelligence model to better identify atrial fibrillation patients who need anticoagulation therapy to...
CRISPR Efficiency Tripled by DNA-Wrapped Nanoparticles
A transformative advance in genome editing technology reports that wrapping CRISPR components in DNA-coated nanoparticles significantly enhances editing efficiency, tripling successful gene...
Novel Antibody-Drug Conjugate Targets Aggressive Lung Cancer
Researchers have introduced SC134-deruxtecan, a new antibody-drug conjugate designed to selectively target fucosyl-GM1 in small cell lung cancer (SCLC), a notoriously aggressive malignancy with...
Insights Into Liver Fibrosis Halted by miR-125a-5p Manipulation
A recent study highlights microRNA miR-125a-5p as a key inhibitor of hepatic stellate cell activation by modulating the TGF-β/Smad2/3 signaling pathway, attenuating liver fibrosis progression....
Advancements in Diabetes Treatment: Polyethylene Glycol Loxenatide and Oral Semaglutide
Recent studies provide real-world evidence supporting the benefits of polyethylene glycol loxenatide combined with basal insulin for type 2 diabetes management, as well as oral semaglutide's role...
Venom-Derived Antimicrobials: AI Unlocks New Therapeutic Candidates
Leveraging artificial intelligence, researchers have mined venom peptides from snakes, spiders, and scorpions to identify novel antimicrobial compounds demonstrating potent activity against...
Liquid Biopsy Biomarker: Fecal miR-92a for Colorectal Cancer Screening
Groundbreaking research has identified fecal microRNA miR-92a as a sensitive, non-invasive biomarker for advanced colorectal neoplasia screening. This innovation offers an accessible alternative...
Advancing Blood Cancer Awareness: Biotech Innovations on the Horizon
As Blood Cancer Awareness Month commences, industry insights reveal promising biotechnological advancements across hematological malignancies. Pipeline developments include novel immunotherapies,...